Showing results (1571-1580 of 1,680) with videos related to
Sort By:
Pageof 168
Circulation. Heart Failure|May 3, 2018
Load-Dependent Changes in Left Ventricular Structure and Function in a Pathophysiologically Relevant Murine Model of Reversible Heart FailureCarla J Weinheimer, Attila Kovacs, Sarah Evans, et al.Circulation. Heart Failure|July 8, 2018
Sarcomeric Auto-Oscillations in Single Myofibrils From the Heart of Patients With Dilated CardiomyopathyTatsuya Kagemoto, Kotaro Oyama, Mitsunori Yamane, et al.Circulation. Heart Failure|July 12, 2018
Left Ventricular Mass Change After Anthracycline ChemotherapyJennifer H Jordan, Sharon M Castellino, Giselle C Meléndez, et al.Circulation. Heart Failure|July 13, 2018
Data-Driven Approach to Identify Subgroups of Heart Failure With Reduced Ejection Fraction Patients With Different Prognoses and Aldosterone Antagonist Response PatternsJoão Pedro Ferreira, Kevin Duarte, John J V McMurray, et al.Circulation. Heart Failure|March 5, 2010
Defining the optimal prognostic window for cardiopulmonary exercise testing in patients with heart failureRoss Arena, Jonathan Myers, Joshua Abella, et al.Circulation. Heart Failure|March 5, 2010
Osteopontin expression in cardiomyocytes induces dilated cardiomyopathyMarie-Ange Renault, Fanny Robbesyn, Patricia Réant, et al.Circulation. Heart Failure|May 4, 2017
Accuracy of Seattle Heart Failure Model and HeartMate II Risk Score in Non-Inotrope-Dependent Advanced Heart Failure Patients: Insights From the ROADMAP Study (Risk Assessment and Comparative Effectiveness of Left Ventricular Assist Device and Medical Management in Ambulatory Heart Failure Patients)David E Lanfear, Wayne C Levy, Josef Stehlik, et al.Circulation. Heart Failure|September 23, 2016
Changes in Left Ventricular Ejection Fraction Predict Survival and Hospitalization in Heart Failure With Reduced Ejection FractionKhadijah Breathett, Larry A Allen, James Udelson, et al.Circulation. Heart Failure|June 3, 2017
Impact of Preeclampsia on Clinical and Functional Outcomes in Women With Peripartum CardiomyopathyKathryn J Lindley, Shayna N Conner, Alison G Cahill, et al.Circulation. Heart Failure|June 15, 2017
Design and Rationale of the Phase 3 ATTR-ACT Clinical Trial (Tafamidis in Transthyretin Cardiomyopathy Clinical Trial)Mathew S Maurer, Perry Elliott, Giampaolo Merlini, et al.Pageof 168